Evidence map›Paper›PMID 36790481›Full record

ReviewMikrochimica acta2023

Signaling strategies of silver nanoparticles in optical and electrochemical biosensors: considering their potential for the point-of-care.

Franziska Beck, Michael Loessl, Antje J Baeumner

Abstract readReview
In one paragraph

Review in Mikrochimica acta, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Optical Bionanosensors for Sepsis Diagnostics.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Rosmarinic Acid-RichMolecules (Basel, Switzerland) · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Franziska BeckInstitute of Analytical Chemistry, Chemo- and Biosensors, University of Regensburg, Regensburg, 93040, Germany.ORCID http://orcid.org/0000-0001-8525-7152
Michael LoesslInstitute of Analytical Chemistry, Chemo- and Biosensors, University of Regensburg, Regensburg, 93040, Germany.ORCID http://orcid.org/0000-0001-6743-2009
Antje J BaeumnerInstitute of Analytical Chemistry, Chemo- and Biosensors, University of Regensburg, Regensburg, 93040, Germany. antje.baeumner@ur.de.ORCID http://orcid.org/0000-0001-7148-3423

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) have long been overshadowed by gold NPs' success in sensor and point-of-care (POC) applications. However, their unique physical, (electro)chemical, and optical properties make them excellently suited for such use, as long as their inherent higher instability toward oxidation is controlled. Recent advances in this field provide novel strategies that demonstrate that the AgNPs' inherent capabilities improve sensor performance and enable the specific detection of analytes at low concentrations. We provide an overview of these advances by focusing on the nanosized Ag (in the range of 1-100 nm) properties with emphasis on optical and electrochemical biosensors. Furthermore, we critically assess their potential for point-of-care sensors discussing advantages as well as limitations for each detection technique. We can conclude that, indeed, strategies using AgNP are ready for sensitive POC applications; however, research focusing on the simplification of assay procedures is direly needed for AgNPs to make the successful jump into actual applications.

Indexed as

Biosensing TechniquesMetal NanoparticlesPoint-of-Care SystemsSilverSurface Plasmon ResonanceSilverClinical analysisElectrochemical biosensorsLocalized surface plasmon resonanceOptical biosensorsPoint-of-careSilver nanoparticles

Identifiers

PMID36790481
PMCPMC9930094

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.